SUVEN PHARMACEUTICALS
Back to Balance Sheet
|
SUVEN PHARMACEUTICALS Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹365 Cr | ₹117 Cr | ₹303 Cr | ₹348 Cr | ₹322 Cr |
What is the latest Total Current Liabilities ratio of SUVEN PHARMACEUTICALS ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹365 Cr |
| Mar2024 | ₹117 Cr |
| Mar2023 | ₹303 Cr |
| Mar2022 | ₹348 Cr |
| Mar2021 | ₹322 Cr |
How is Total Current Liabilities of SUVEN PHARMACEUTICALS Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹365 Cr | 211.06 | |
| Mar2024 | ₹117 Cr | -61.27 | |
| Mar2023 | ₹303 Cr | -12.79 | |
| Mar2022 | ₹348 Cr | 8.09 | |
| Mar2021 | ₹322 Cr | - | |
Compare Total Current Liabilities of peers of SUVEN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUVEN PHARMACEUTICALS | ₹20,497.8 Cr | 1% | -4.4% | -54.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹416,884.0 Cr | -0.5% | -1.9% | -3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,442.0 Cr | 1.8% | 1.3% | 10.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,770.0 Cr | 2% | 2.4% | 11.2% | Stock Analytics | |
| CIPLA | ₹120,871.0 Cr | -0.2% | -0.7% | 1.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,693.0 Cr | -1% | 2.5% | -4.4% | Stock Analytics | |
SUVEN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUVEN PHARMACEUTICALS | 1% |
-4.4% |
-54.6% |
| SENSEX | 1% |
0.6% |
7.8% |
You may also like the below Video Courses